Position in INCY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$42,100,430
+$7,986,072 QoQ
Shares Held
371,387
+2.5% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#74
of 849 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swedbank AB holds $1,373,398,390 across 23 Biotechnology names. INCY ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
10,726,608 | $601,440,910 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
968,092 | $233,281,129 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
282,444 | $140,298,407 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
189,848 | $118,377,821 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,314,787 | $75,232,112 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $45,801,140 | |
| 7 | INCY |
Incyte Corp
This page
|
371,387 | $42,100,430 | |
| 8 | 775,032 | $24,359,255 |
All Filings in INCY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,100,430 | 371,387 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $34,114,358 | 362,456 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $36,271,208 | 367,229 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $31,537,107 | 371,856 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $41,629,121 | 611,294 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $39,191,975 | 567,424 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $44,032,250 | 666,146 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $40,385,771 | 666,212 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $37,440,285 | 657,193 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $39,741,988 | 632,935 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $35,235,713 | 609,931 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $35,112,610 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $40,764,471 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $45,305,138 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $37,588,825 | 564,058 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $43,689,739 | 575,092 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $45,467,314 | 572,492 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $41,045,867 | 559,208 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $38,462,326 | 559,208 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $47,046,169 | 559,208 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $52,885,721 | 650,741 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||